Oesophageal Cancer Trial, Recruiting NCT06346054 Sponsor: KU Leuven Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT06346054
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years old
  • People who have Barrett's esophagus (a condition affecting the lining of the food pipe) or gastro-esophageal cancer (cancer of the stomach or food pipe) that has not yet been treated, at any stage from I to IV
  • Healthy volunteers who are willing to participate as a comparison group
  • People who have given their written agreement to take part (or whose legal representative has done so) before any breath or blood samples are collected

Who may not be able to join:

  • People who are under 18 years old
  • People who currently have another active cancer (other than gastro-esophageal cancer)
  • People who were treated for a different cancer less than 3 years ago
  • People who have significant liver disease or liver failure (confirm with trial site for specific details)
  • People who have any other health condition or situation that the trial doctor believes could affect their safety or ability to follow the study plan
  • People whose breath or blood samples are not of sufficient quality to be reliably analysed
  • People who are currently incarcerated

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stijn Vanstraelen, MD, Universitaire Ziekenhuizen KU Leuven

Phone: 16347863

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
KU Leuven
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
1 July 2029

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Identification of the concentrations of oncometabolites

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov